LYRA
Price
$6.47
Change
+$0.11 (+1.73%)
Updated
Sep 26 closing price
Capitalization
10.64M
TBPH
Price
$14.07
Change
+$0.28 (+2.03%)
Updated
Sep 26 closing price
Capitalization
708.58M
39 days until earnings call
Interact to see
Advertisement

LYRA vs TBPH

Header iconLYRA vs TBPH Comparison
Open Charts LYRA vs TBPHBanner chart's image
Lyra Therapeutics
Price$6.47
Change+$0.11 (+1.73%)
Volume$7.27K
Capitalization10.64M
Theravance Biopharma
Price$14.07
Change+$0.28 (+2.03%)
Volume$309.11K
Capitalization708.58M
LYRA vs TBPH Comparison Chart in %
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. TBPH commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Buy and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (LYRA: $6.47 vs. TBPH: $14.07)
Brand notoriety: LYRA and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 37% vs. TBPH: 72%
Market capitalization -- LYRA: $10.64M vs. TBPH: $708.58M
LYRA [@Biotechnology] is valued at $10.64M. TBPH’s [@Biotechnology] market capitalization is $708.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 1 green FA rating(s).

  • LYRA’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 1 green, 4 red.
According to our system of comparison, TBPH is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 5 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • LYRA’s TA Score: 5 bullish, 2 bearish.
  • TBPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than TBPH.

Price Growth

LYRA (@Biotechnology) experienced а +1.89% price change this week, while TBPH (@Biotechnology) price change was +1.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

TBPH is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($709M) has a higher market cap than LYRA($10.6M). TBPH YTD gains are higher at: 49.522 vs. LYRA (-37.306). TBPH has higher annual earnings (EBITDA): 46.1M vs. LYRA (-35.34M). TBPH has more cash in the bank: 339M vs. LYRA (29.8M). LYRA has less debt than TBPH: LYRA (32.5M) vs TBPH (46.5M). TBPH has higher revenues than LYRA: TBPH (77.2M) vs LYRA (770K).
LYRATBPHLYRA / TBPH
Capitalization10.6M709M1%
EBITDA-35.34M46.1M-77%
Gain YTD-37.30649.522-75%
P/E RatioN/A58.63-
Revenue770K77.2M1%
Total Cash29.8M339M9%
Total Debt32.5M46.5M70%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
35
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYRATBPH
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FESAX11.500.11
+0.97%
First Eagle Small Cap Opportunity A
GMNAX12.000.10
+0.84%
Gabelli Global Mini Mites A
JRSNX13.070.08
+0.62%
JH Adaptive Risk Mgd U.S. Eq N
ADGAX26.330.12
+0.46%
AB Core Opportunities A
WSTYX78.510.11
+0.14%
Macquarie Science and Technology Y

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+1.73%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
+5.38%
VERA - LYRA
53%
Loosely correlated
+4.60%
KYMR - LYRA
52%
Loosely correlated
+4.68%
CLNN - LYRA
39%
Loosely correlated
+0.09%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+2.03%
KYMR - TBPH
49%
Loosely correlated
+4.68%
VERA - TBPH
38%
Loosely correlated
+4.60%
LYRA - TBPH
37%
Loosely correlated
+1.73%
RGNX - TBPH
36%
Loosely correlated
+3.10%
APLS - TBPH
34%
Loosely correlated
+0.68%
More